Invention Grant
- Patent Title: Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent Title (中): 2,4-嘧啶二胺化合物的前药及其用途
-
Application No.: US13418306Application Date: 2012-03-12
-
Publication No.: US08445485B2Publication Date: 2013-05-21
- Inventor: Somasekhar Bhamidipati , Rajinder Singh , Thomas Sun , Esteban Masuda
- Applicant: Somasekhar Bhamidipati , Rajinder Singh , Thomas Sun , Esteban Masuda
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: A61K31/5383
- IPC: A61K31/5383
Abstract:
The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.
Public/Granted literature
- US20120208785A1 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses Public/Granted day:2012-08-16
Information query
IPC分类:
